Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Pawan, Dulal"'
Autor:
Kyprianos Michaelides, Maruthi Prasanna, Raj Badhan, Afzal-Ur-Rahman Mohammed, Adam Walters, M. Keith Howard, Pawan Dulal, Ali Al-Khattawi
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 579-595 (2023)
Introduction With a limited global supply of vaccines and an increasing vaccine hesitancy, improving vaccination coverage has become a priority. Current vaccination regimes require multiple doses to be administered in a defined schedule where missed
Externí odkaz:
https://doaj.org/article/0a7e7263138e46adbf5b7ed04c0cf03c
Autor:
Pawan Dulal, Robabeh Gharaei, Adam J. Berg, Adam A. Walters, Nicholas Hawkins, Tim D. W. Claridge, Katarzyna Kowal, Steven Neill, Adam J. Ritchie, Rebecca Ashfield, Adrian V. S. Hill, Giuseppe Tronci, Stephen J. Russell, Alexander D. Douglas
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Adenovirus vectors offer a platform technology for vaccine development. The value of the platform has been proven during the COVID-19 pandemic. Although good stability at 2–8 °C is an advantage of the platform, non-cold-chain distribution
Externí odkaz:
https://doaj.org/article/9a17d15607764d48a6123bce56f342f2
Autor:
Ellie Hayhurst, Emily Rose, Miriam Pedrera, Jane C. Edwards, Natalia Kotynska, Daisy Grainger, Yashar Sadigh, John Flannery, Ludo Bonnet, Ritwik Ritwik, Pawan Dulal, M. Keith Howard, Simon P. Graham
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1836 (2022)
Solid dose vaccine formulation and delivery systems offer potential advantages over traditional liquid vaccine formulations. In addition to enhanced thermostability, needle-free delivery of unit solid dose injectable (USDI) vaccines offers safe, rapi
Externí odkaz:
https://doaj.org/article/ea649871c3934d728b73b37f2625dd8d
Autor:
Pawan Dulal, Robabeh Gharaei, Adam Berg, Adam A. Walters, Nicholas Hawkins, Tim D. W. Claridge, Katarzyna Kowal, Steven Neill, Adam J. Ritchie, Rebecca Ashfield, Adrian V. S. Hill, Giuseppe Tronci, Stephen J. Russell, Alexander D. Douglas
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
The original version of this Article contained an error.
Externí odkaz:
https://doaj.org/article/408e1a4ae9a94b74840902511af1bdea
Autor:
Adam Berg, Daniel Wright, Pawan Dulal, Anna Stedman, Sofiya Fedosyuk, Michael J. Francis, Bryan Charleston, George M. Warimwe, Alexander D. Douglas
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1249 (2021)
Adenovirus vectored vaccines have entered global use during the COVID-19 pandemic, and are in development for multiple other human and veterinary applications. An attraction of the technology is the suitability of the vaccines for storage at 2–8 °
Externí odkaz:
https://doaj.org/article/afc0a50e705742ddac58b0fa77740ec1
Autor:
Chuan Wang, Pawan Dulal, Xiangyang Zhou, Zhiquan Xiang, Hooman Goharriz, Ashley Banyard, Nicky Green, Livia Brunner, Roland Ventura, Nicolas Collin, Simon J Draper, Adrian V S Hill, Rebecca Ashfield, Anthony R Fooks, Hildegund C Ertl, Alexander D Douglas
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 12, Iss 10, p e0006870 (2018)
BACKGROUND:Estimates of current global rabies mortality range from 26,000 to 59,000 deaths per annum. Although pre-exposure prophylaxis using inactivated rabies virus vaccines (IRVs) is effective, it requires two to three doses and is regarded as bei
Externí odkaz:
https://doaj.org/article/5001056cafa2462c8e1c18be10355d9e
Autor:
Adrian V. S. Hill, Stephen J. Russell, Katarzyna Kowal, Pawan Dulal, Adam Berg, Adam J. Ritchie, Nicholas Hawkins, Adam A Walters, Robabeh Gharaei, Giuseppe Tronci, Alexander D. Douglas, Timothy D. W. Claridge, Rebecca Ashfield, Steven Neill
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-1 (2021)
Adenovirus vectors offer a platform technology for vaccine development. The value of the platform has been proven during the COVID-19 pandemic. Although good stability at 2-8 °C is an advantage of the platform, non-cold-chain distribution would have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfe1458eeb376cf5e0d81e0e55f79ec9
https://doi.org/10.1038/s41598-021-02406-9
https://doi.org/10.1038/s41598-021-02406-9
Autor:
Anna Stedman, Bryan Charleston, Michael J. Francis, Sofiya Fedosyuk, Alexander D. Douglas, Pawan Dulal, George M. Warimwe, Adam Berg, Daniel Wright
Publikováno v:
Vaccines
Volume 9
Issue 11
Vaccines, Vol 9, Iss 1249, p 1249 (2021)
Volume 9
Issue 11
Vaccines, Vol 9, Iss 1249, p 1249 (2021)
Adenovirus vectored vaccines have entered global use during the COVID-19 pandemic, and are in development for multiple other human and veterinary applications. An attraction of the technology is the suitability of the vaccines for storage at 2–8 °
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5b14d76cde505bb43907f584eaccfeb
Autor:
Steven Neill, Katarzyna Kowal, Alexander D. Douglas, Nicholas Hawkins, Timothy D. W. Claridge, Adam A Walters, Adam J. Ritchie, Adrian V. S. Hill, Stephen J. Russell, Rebecca Ashfield, Pawan Dulal
The global network of fridges and freezers known as the “cold chain” can account for a significant proportion of the total cost of vaccination and is susceptible to failure. Cost-efficient techniques to enhance stability of vaccines could prevent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06852fff4cfee6e99dedffe301c3a09a
https://doi.org/10.1101/2020.01.31.928218
https://doi.org/10.1101/2020.01.31.928218
Autor:
Jing, Jin, Richard D, Tarrant, Emma J, Bolam, Philip, Angell-Manning, Max, Soegaard, David J, Pattinson, Pawan, Dulal, Sarah E, Silk, Jennifer M, Marshall, Rebecca A, Dabbs, Fay L, Nugent, Jordan R, Barrett, Kathryn A, Hjerrild, Lars, Poulsen, Thomas, Jørgensen, Tanja, Brenner, Ioana N, Baleanu, Helena M, Parracho, Abdessamad, Tahiri-Alaoui, Gary, Whale, Sarah, Moyle, Ruth O, Payne, Angela M, Minassian, Matthew K, Higgins, Frank J, Detmers, Alison M, Lawrie, Alexander D, Douglas, Robert, Smith, Willem A, de Jongh, Eleanor, Berrie, Rebecca, Ashfield, Simon J, Draper
Publikováno v:
NPJ Vaccines
Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is a leading asexual blood-stage vaccine candidate for malaria. In preparation for clinical trials, a full-length PfRH5 protein vaccine called “RH5.1” was produced as a soluble
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2f50c213b127b11b847cd96aa8220f18
https://pubmed.ncbi.nlm.nih.gov/30131879
https://pubmed.ncbi.nlm.nih.gov/30131879